Alp Bio AG’s Pre-Seed Round Accelerates Early Immunogenicity Screening Technology

Kellerhals Carrard advised Alp Bio AG on all legal aspects of its USD 2.2 million pre-seed financing round. Alp Bio AG has completed a USD 2.2…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here